{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:34:20Z","timestamp":1768073660882,"version":"3.49.0"},"reference-count":128,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:00:00Z","timestamp":1694304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lublin, Poland","award":["167"],"award-info":[{"award-number":["167"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Psoriasis is nowadays recognized as a multifactorial systemic disease with complex and not fully understood pathogenesis. In psoriatic patients, the increased cardiovascular disease (CVD) risk and frequent comorbidities like obesity are observed. The aim of this study was to investigate differences in miRNA (miR-22-3p, miR-133a-3p, miR-146a-5p, miR-369-3p, and Let-7b-5p) involved in CVD risk among psoriatic patients with overweight\/obesity and with normal weight. The study comprised 28 male psoriatic patients and 16 male healthy controls. miRNA isolated from peripheral blood mononuclear cells was reverse-transcribed and RT-qPCR was performed. We have found decreased levels of miR-22, miR-133a, miR-146a, and miR-369 among the psoriatic patients. There was a statistically significant difference in miR-22 and miR-146a levels between psoriatic patients with overweight\/obesity and with normal weight. There were positive correlations between miR-22 and miR-146a levels and psoriatic arthritis (PsA) in psoriatic patients with normal weight and between the miR-133a level and PsA in the overweight\/obese patients. The decreased levels of selected miRNA are consistent with the levels observed in CVD indicating their impact on the CVD risk in psoriatic patients. miR-22 and miR-146 may be recognized as one of the contributing factors in the obesity-CVD-psoriasis network.<\/jats:p>","DOI":"10.3390\/ijms241813916","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T09:00:52Z","timestamp":1694422852000},"page":"13916","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Selected miRNA and Psoriasis\u2014Cardiovascular Disease (CVD)\u2014Overweight\/Obesity Network\u2014A Pilot Study"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4599-6249","authenticated-orcid":false,"given":"Anna","family":"Michalak-Stoma","sequence":"first","affiliation":[{"name":"Chair and Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-8289","authenticated-orcid":false,"given":"Katarzyna","family":"Walczak","sequence":"additional","affiliation":[{"name":"Chair and Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-7840","authenticated-orcid":false,"given":"Micha\u0142","family":"Adamczyk","sequence":"additional","affiliation":[{"name":"Chair and Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Kowal","sequence":"additional","affiliation":[{"name":"Chair and Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-9870","authenticated-orcid":false,"given":"Dorota","family":"Krasowska","sequence":"additional","affiliation":[{"name":"Chair and Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, ul. Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dopytalska, K., Ciechanowicz, P., Wiszniewski, K., Szyma\u0144ska, E., and Walecka, I. (2021). The Role of Epigenetic Factors in Psoriasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179294"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102614","DOI":"10.1016\/j.jaut.2021.102614","article-title":"Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities","volume":"118","author":"Srivastava","year":"2021","journal-title":"J. Autoimmun."},{"key":"ref_3","first-page":"40","article-title":"The role of IL-23 in the immunopathogenesis of psoriasis","volume":"2","author":"Nestle","year":"2010","journal-title":"F1000 Biol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5114\/ada.2020.96243","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part II. Genetic, genomic and epigenetic changes in psoriasis","volume":"37","author":"Nedoszytko","year":"2020","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kisiel, B., Kisiel, K., Szyma\u0144ski, K., Mackiewicz, W., Bia\u0142o-W\u00f3jcicka, E., Uczniak, S., Fogtman, A., Iwanicka-Nowicka, R., Koblowska, M., and Kossowska, H. (2017). The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179348"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kisielnicka, A., Sobalska-Kwapis, M., Purzycka-Bohdan, D., Nedoszytko, B., Zab\u0142otna, M., Seweryn, M., Strapagiel, D., Nowicki, R.J., Reich, A., and Samotij, D. (2022). The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in Psoriasis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137396"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5114\/ada.2020.98284","article-title":"Pathogenesis of psoriasis in the \u201comic\u201d era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis","volume":"37","author":"Nedoszytko","year":"2020","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Purzycka-Bohdan, D., Kisielnicka, A., Bohdan, M., Szczerkowska-Dobosz, A., Sobalska-Kwapis, M., Nedoszytko, B., and Nowicki, R.J. (2021). Analysis of the Potential Genetic Links between Psoriasis and Cardiovascular Risk Factors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22169063"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors","volume":"27","author":"Lechner","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1534\/genetics.111.131912","article-title":"Environment-Sensitive Epigenetics and the Heritability of Complex Diseases","volume":"189","author":"Furrow","year":"2011","journal-title":"Genetics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.apcsb.2016.09.003","article-title":"Epigenetic Changes in Chronic Inflammatory Diseases","volume":"Volume 106","author":"Fogel","year":"2017","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/1346-8138.13806","article-title":"Critical role of environmental factors in the pathogenesis of psoriasis","volume":"44","author":"Zeng","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/exd.14332","article-title":"Dysregulated epigenetic modifications in psoriasis","volume":"30","author":"Zeng","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sonkoly, E., Wei, T., Janson, P.C., S\u00e4\u00e4f, A., Lundeberg, L., Tengvall-Linder, M., Norstedt, G., Alenius, H., Homey, B., and Scheynius, A. (2007). MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis?. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000610"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/JID.2015.409","article-title":"microRNAs in Psoriasis","volume":"136","author":"Hawkes","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1515\/med-2016-0063","article-title":"MicroRNAs as regulatory elements in psoriasis","volume":"11","author":"Liu","year":"2016","journal-title":"Open Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers","volume":"26","author":"Liu","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_19","first-page":"1561278","article-title":"Plasma MicroRNA Expression Profiles in Psoriasis","volume":"16","author":"Xiao","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.abd.2020.07.001","article-title":"Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity","volume":"95","author":"Alatas","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Domingo, S., Sol\u00e9, C., Molin\u00e9, T., Ferrer, B., and Cort\u00e9s-Hern\u00e1ndez, J. (2020). MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis. Cells, 9.","DOI":"10.3390\/cells9122656"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40291-021-00531-9","article-title":"Serum Levels of miR-146a in Patients with Psoriasis","volume":"25","author":"Leal","year":"2021","journal-title":"Mol. Diagn. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jdv.12001","article-title":"Obesity, waist circumference, weight change and the risk of psoriasis in US women: Risk of psoriasis in US women","volume":"27","author":"Kumar","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and Obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jid.2017.07.822","article-title":"Obesity, Waist Circumference, Weight Change, and Risk of Incident Psoriasis: Prospective Data from the HUNT Study","volume":"137","author":"Snekvik","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_26","first-page":"761","article-title":"Compounds of psoriasis with obesity and overweight","volume":"71","author":"Placek","year":"2017","journal-title":"Postep. Hig. Med. Dosw."},{"key":"ref_27","first-page":"CD011972","article-title":"Lifestyle changes for treating psoriasis","volume":"7","author":"Chi","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bjd.18327","article-title":"Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: Analysis of two randomized controlled trials","volume":"182","author":"Hsu","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaad.2021.06.012","article-title":"Risk of psoriasis according to body mass index: A retrospective cohort analysis","volume":"86","author":"Norden","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Barros, G., Duran, P., Vera, I., and Berm\u00fadez, V. (2022). Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147499"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Budu-Aggrey, A., Brumpton, B., Tyrrell, J., Watkins, S., Modalsli, E.H., Celis-Morales, C., Ferguson, L.D., Vie, G.\u00c5., Palmer, T., and Fritsche, L.G. (2019). Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Med., 16.","DOI":"10.1371\/journal.pmed.1002739"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5551\/jat.3939","article-title":"Adipose tissue, inflammation and atherosclerosis","volume":"17","author":"Gustafson","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ad.2012.08.003","article-title":"Obesity and psoriasis: Inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications","volume":"105","author":"Carrascosa","year":"2014","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/eji.200838893","article-title":"Obesity predisposes to Th17 bias","volume":"39","author":"Winer","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cytogfr.2010.10.005","article-title":"IL-17 in obesity and adipogenesis","volume":"21","author":"Ahmed","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbalip.2016.02.010","article-title":"miRNA regulation of white and brown adipose tissue differentiation and function","volume":"1861","author":"Price","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Landrier, J.-F., Derghal, A., and Mounien, L. (2019). MicroRNAs in Obesity and Related Metabolic Disorders. Cells, 8.","DOI":"10.3390\/cells8080859"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gharanei, S., Shabir, K., Brown, J.E., Weickert, M.O., Barber, T.M., Kyrou, I., and Randeva, H.S. (2020). Regulatory microRNAs in Brown, Brite and White Adipose Tissue. Cells, 9.","DOI":"10.3390\/cells9112489"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","article-title":"The \u201cpsoriatic march\u201d: A concept of how severe psoriasis may drive cardiovascular comorbidity","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehn387","article-title":"Adipose tissue dysfunction in obesity, diabetes, and vascular diseases","volume":"29","author":"Hajer","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_42","unstructured":"(2023, May 14). miRNet\u2014A miRNA-Centric Network Visual Analytics Platform. Available online: https:\/\/www.mirnet.ca\/miRNet\/home.xhtml."},{"key":"ref_43","unstructured":"World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation, World Health Organization."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2009\/757683","article-title":"Use of obesity biomarkers in cardiovascular epidemiology","volume":"26","author":"Pischon","year":"2009","journal-title":"Dis. Markers"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.12.006","article-title":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","volume":"92","author":"Nimptsch","year":"2019","journal-title":"Metabolism"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ejcn.2009.139","article-title":"Body fat distribution and noncommunicable diseases in populations: Overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio","volume":"64","author":"Nishida","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_47","first-page":"7420823","article-title":"IL-17A in the Psoriatic Patients\u2019 Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity","volume":"2020","author":"Kowal","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/VB-21-0007","article-title":"microRNAs involved in psoriasis and cardiovascular diseases","volume":"3","author":"Sileno","year":"2021","journal-title":"Vasc. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kadye, R., Stoffels, M., Fanucci, S., Mbanxa, S., and Prinsloo, E. (2020). A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment. Cells, 9.","DOI":"10.3390\/cells9041043"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2017.02.078","article-title":"Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study","volume":"235","author":"Akkerhuis","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCRESAHA.112.300682","article-title":"MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress","volume":"112","author":"Huang","year":"2013","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.repc.2021.03.020","article-title":"Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review","volume":"41","author":"Figueiredo","year":"2022","journal-title":"Rev. Port. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1161\/CIRCULATIONAHA.117.027799","article-title":"miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation","volume":"137","author":"Yang","year":"2018","journal-title":"Circulation"},{"key":"ref_54","first-page":"1","article-title":"Expression levels of miR-22, miR-30c, miR-145, and miR-519d and their possible associations with inflammatory markers among patients with coronary artery disease","volume":"18","author":"Ghorbani","year":"2022","journal-title":"ARYA Atheroscler. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1002\/jcp.27274","article-title":"Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00259-013-2596-3","article-title":"In vitro and in vivo direct monitoring of miRNA-22 expression in isoproterenol-induced cardiac hypertrophy by bioluminescence imaging","volume":"41","author":"Tu","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tcm.2014.07.005","article-title":"miR-22 in cardiac remodeling and disease","volume":"24","author":"Huang","year":"2014","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Gurha, P., Wang, T., Larimore, A.H., Sassi, Y., Abreu-Goodger, C., Ramirez, M.O., Reddy, A.K., Engelhardt, S., Taffet, G.E., and Wehrens, X.H.T. (2013). microRNA-22 promotes heart failure through coordinate suppression of PPAR\/ERR-nuclear hormone receptor transcription. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075882"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jacc.2016.07.739","article-title":"Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction","volume":"68","author":"Gupta","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.imlet.2012.09.004","article-title":"Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions","volume":"148","author":"Xia","year":"2012","journal-title":"Immunol. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jdv.13861","article-title":"Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity","volume":"31","author":"Navarro","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jid.2017.05.012","article-title":"miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis","volume":"137","author":"Hermann","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/exd.12604","article-title":"Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis","volume":"24","author":"Mitsui","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e24198","DOI":"10.1002\/jcla.24198","article-title":"MicroRNA-146a and microRNA-146b deficiency correlates with exacerbated disease activity, and their longitude increment relates to etanercept response in psoriasis patients","volume":"36","author":"Shen","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jdermsci.2014.01.005","article-title":"Analysis of expression pattern of serum microRNA levels in patients with psoriasis","volume":"74","author":"Koga","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","article-title":"MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis","volume":"139","author":"Srivastava","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"646796","DOI":"10.3389\/fmed.2021.646796","article-title":"miRNAs Flowing Up and Down: The Concerto of Psoriasis","volume":"26","author":"Xiuli","year":"2021","journal-title":"Front. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/jid.2014.89","article-title":"MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes","volume":"134","author":"Meisgen","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1074\/jbc.M117.809780","article-title":"MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2","volume":"293","author":"Shams","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101374","DOI":"10.1016\/j.arr.2021.101374","article-title":"miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases","volume":"70","author":"Olivieri","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","article-title":"A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases","volume":"227","author":"Aslani","year":"2020","journal-title":"Immunol. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.310529","article-title":"Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a","volume":"121","author":"Cheng","year":"2017","journal-title":"Circ. Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/mmr.2014.3107","article-title":"MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway","volume":"11","author":"Cao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.febslet.2011.01.010","article-title":"MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"379537","DOI":"10.1155\/2014\/379537","article-title":"MicroRNA-146a decreases high glucose\/thrombin-induced endothelial inflammation by inhibiting NAPDH oxidase 4 expression","volume":"2014","author":"Wang","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.febslet.2011.02.009","article-title":"MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4","volume":"585","author":"Yang","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCRESAHA.118.312751","article-title":"miR-146a suppresses SUMO1 expression and induces cardiac dysfunction in maladaptive hypertrophy","volume":"123","author":"Oh","year":"2018","journal-title":"Circ. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/1074248420922793","article-title":"A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine","volume":"25","author":"Barraclough","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-019-0086-1","article-title":"Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction","volume":"25","author":"Xue","year":"2019","journal-title":"Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/icb.2010.16","article-title":"miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome","volume":"88","author":"Guo","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0022034510378683","article-title":"Epigenetic mechanisms in inflammation","volume":"90","author":"Bayarsaihan","year":"2011","journal-title":"J. Dent. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00011-020-01425-y","article-title":"Epigenetic signatures underlying inflammation: An interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition","volume":"70","author":"Milagro","year":"2021","journal-title":"Inflamm. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/2211536607666180402120806","article-title":"Influence of Overweight and Obesity on Circulating Inflammation-Related microRNA","volume":"7","author":"Hijmans","year":"2018","journal-title":"MicroRNA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.clnu.2018.09.024","article-title":"Circulating microRNAs and adipokines as markers of metabolic syndrome in adolescents with obesity","volume":"38","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1080\/13813455.2020.1775655","article-title":"Circulating mir-21 and mir-146a are associated with increased cytokines and CD36 in Algerian obese male participants","volume":"128","author":"Benbaibeche","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Liu, W., Bi, P., Shan, T., Yang, X., Yin, H., Wang, Y.-X., Liu, N., Rudnicki, M.A., and Kuang, S. (2013). miR-133a regulates adipocyte browning in vivo. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003626"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cmet.2013.01.004","article-title":"MicroRNA-133 Controls Brown Adipose Determination in Skeletal Muscle Satellite Cells by Targeting Prdm16","volume":"17","author":"Yin","year":"2013","journal-title":"Cell Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/ncb2612","article-title":"MyomiR-133 regulates brown fat differentiation through Prdm16","volume":"14","author":"Trajkovski","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"926912","DOI":"10.1155\/2015\/926912","article-title":"Relation between Birth Weight, Growth, and Subclinical Atherosclerosis in Adulthood","volume":"2015","author":"Valente","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4161\/adip.22296","article-title":"Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance","volume":"2","author":"Wu","year":"2013","journal-title":"Adipocyte"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Vijgen, G.H.E.J., Bouvy, N.D., Teule, G.J.J., Brans, B., Schrauwen, P., and Lichtenbelt, W.D.V.M. (2011). Brown Adipose Tissue in Morbidly Obese Subjects. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017247"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/obr.12277","article-title":"What childhood obesity prevention programmes work? A systematic review and meta-analysis","volume":"16","author":"Wang","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biopha.2018.01.019","article-title":"Down-regulation of miR-133a\/b in patients with myocardial infarction correlates with the presence of ventricular fibrillation","volume":"99","author":"Brandner","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000268088","article-title":"MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction","volume":"115","author":"Zidar","year":"2010","journal-title":"Cardiology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Catalucci","year":"2007","journal-title":"Nat. Med."},{"key":"ref_99","first-page":"4356","article-title":"Effect of microRNA-133a-3p\/matrix metalloproteinase-9 axis on the growth of atherosclerotic vascular smooth muscle cells","volume":"18","author":"Shi","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1210\/en.2012-2236","article-title":"MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells","volume":"154","author":"Liao","year":"2013","journal-title":"Endocrinology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","article-title":"Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage","volume":"4","author":"Kuwabara","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1684\/ejd.2013.2148","article-title":"Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity","volume":"23","author":"Guo","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"15942","DOI":"10.1038\/s41598-020-72991-8","article-title":"miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response","volume":"10","author":"Scalavino","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e10550","DOI":"10.1590\/1414-431x202010550","article-title":"MicroRNA-369 attenuates hypoxia-induced cardiomyocyte apoptosis and inflammation via targeting TRPV3","volume":"54","author":"Wang","year":"2021","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3892\/mmr.2015.3422","article-title":"A subset of circulating microRNAs is expressed differently in patients with myocardial infarction","volume":"12","author":"Liang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12964-018-0271-9","article-title":"MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis","volume":"16","author":"Wu","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"577640","DOI":"10.1016\/j.jneuroim.2021.577640","article-title":"The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases","volume":"358","author":"Mirzaei","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.16203","article-title":"Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis","volume":"34","author":"Pasquali","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_109","first-page":"5742608","article-title":"Identification of Candidate Genes and MicroRNAs for Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis","volume":"2019","author":"Li","year":"2019","journal-title":"Biomed Res Int."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective effect of let-7 mirna family in regulating inflammation in diabetes-associated atherosclerosis","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/hmg\/ddy008","article-title":"Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients","volume":"27","author":"Barbarroja","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3899\/jrheum.190602","article-title":"Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis","volume":"47","author":"Wade","year":"2020","journal-title":"J. Rheumatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/17512433.2017.1329009","article-title":"Tumor necrosis factor inhibitors in psoriatic arthritis","volume":"10","author":"Mantravadi","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s10067-019-04663-6","article-title":"Psoriatic arthritis and obesity: The role of anti-IL-12\/IL-23 treatment","volume":"38","author":"Costa","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-013-2369-1","article-title":"Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients","volume":"33","author":"Costa","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis","volume":"86","author":"Shan","year":"2018","journal-title":"Jt. Bone Spine"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Singh, S., Facciorusso, A., Singh, A.G., Casteele, N.V., Zarrinpar, A., Prokop, L.J., Grunvald, E.L., Curtis, J.R., and Sandborn, W.J. (2018). Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195123"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"662047","DOI":"10.3389\/fmolb.2021.662047","article-title":"The Molecular Pathophysiology of Psoriatic Arthritis-The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome","volume":"8","author":"Carvalho","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-3083.2010.02381.x","article-title":"The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility","volume":"71","author":"Chatzikyriakidou","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2014.00553","article-title":"IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance","volume":"5","author":"Jain","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Lin, S.-H., Ho, J.-C., Li, S.-C., Chen, J.-F., Hsiao, C.-C., and Lee, C.-H. (2019). MiR-146a-5p expression in peripheral CD14+ monocytes from patients with psoriatic arthritis induces osteoclast activation, bone resorption, and correlates with clinical response. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010110"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Caputo, V., Strafella, C., Termine, A., Campione, E., Bianchi, L., Novelli, G., Giardina, E., and Cascella, R. (2020). RNAseq-based prioritization revealed COL6A5, COL8A1, COL10A1 and MIR146A as common and differential susceptibility biomarkers for psoriasis and psoriatic arthritis: Confirmation from genotyping analysis of 1417 Italian subjects. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082740"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12933-020-01107-3","article-title":"MicroRNAs and obesity-induced endothelial dysfunction: Key paradigms in molecular therapy","volume":"19","author":"Nguyen","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","article-title":"Animal models of psoriasis\u2014Highlights and drawbacks","volume":"147","author":"Manzke","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/jid.2012.260","article-title":"CCR6 is required for epidermal trafficking of \u03b3\u03b4-T cells in an IL-23-induced model of psoriasiform dermatitis","volume":"133","author":"Mabuchi","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/13916\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:48:15Z","timestamp":1760129295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/13916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,10]]},"references-count":128,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241813916"],"URL":"https:\/\/doi.org\/10.3390\/ijms241813916","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,10]]}}}